Omeprazole and analogue compounds: A QSAR study of activity against Helicobacter pylori using theoretical descriptors

Journal of Chemometrics

Volumn 16, Issue 8-10, 2002, Pages 510-520

  Bruni, Aline Thais ^a   Ferreira, Márcia Miguel Castro ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Chemometrics; Helicobacter pylori; Omeprazole; PLS; Quantum chemistry

Indexed keywords

COMPUTATIONAL CHEMISTRY; CONFORMATIONS;

AB INITIO METHOD; BASIS SETS; CHEMOMETRICES; CONFORMATIONAL ANALYSIS; DESCRIPTORS; HELICOBACTER PYLORI; MINIMUM-ENERGY STRUCTURES; OMEPRAZOLE; PLS; QSAR STUDIES;

QUANTUM CHEMISTRY;

OMEPRAZOLE; OMEPRAZOLE DERIVATIVE;

AB INITIO CALCULATION; CONFERENCE PAPER; DRUG STRUCTURE; ENERGY TRANSFER; HELICOBACTER PYLORI; MATHEMATICAL ANALYSIS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; THEORY; THERMODYNAMICS; VALIDATION PROCESS;

EID: 0036685318     PISSN: 08869383     EISSN: None     Source Type: Journal    
DOI: 10.1002/cem.737     Document Type: Conference Paper

References (45)

1. Computational methods for the structural alignment of molecules
2. Strategies for indirect computer-aided drug design
3. The role of computational medicinal chemistry in the drug discovery process
4. 3D-QSAR: Current state, scope, and limitations
5. GOLPE-guided region selection
6. 3D QSAR of flexible molecules using tensor representation
7. Some biological applications of semiempirical MO theory
8. Density functional theory and molecular dynamics: A new perspective for simulations of biological systems
9. Quantum mechanical origin of QSAR: Theory and applications
10. Similarity and dissimilarity: A medicinal chemist's view
11. Smart region definition: A new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships
12. Chemometric methodologies in quantitative structure-activity relationship study: The antibacterial activity of 6-aminoquinolonas
13. 3 receptor subtype
14. A unified framework for using neural networks to build QSARs
15. Evolutionary optimization in quantitative structure- activity relationship: An application of genetic neural networks
16. A receptors
17. Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles
18. Anti-Helicobacter pylori agents. 1. 2-(Alkylguanidino)-4-furylthiazoles and related compounds
19. Drug therapy for Helicobacter pylori infection: Problems and pitfalls
20. Meta analysis and efficacy of antibiotic therapy in eradicating Helicobacter pylori
21. Long-term consequences of Helicobacter pylori eradication Scand
22. Treatment strategies for symptom resolution, healing, and Helicobacter pylori eradication in duodenal ulcer patients
23. Future research in peptic ulcer disease
24. Helicobacter pylori eradication: The rational treatment for peptic ulcer disease -chairmen's conclusion
25. The mechanism of action of the gastric-acid secretion inhibitor omprazole
26. Helicobacter pylori
27. Structure-activity relationship of omeprazole and analogues as Helicobacter pylori urease inhibitors
28. Differential stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor in extensive and poor metabolizers of pantoprazole - A preliminary study
29. Clinical pharmacokinetics of lansoprazole
30. Optimization of parameters for semiempirical methods. 1. Method
31. Conformational analysis: A new approach by means of chemometrics
32. Systematic search in conformational analysis
33. Atomic physicochemical parameters for three-dimensional structure directed quantitative structure-activity relationships. III: Modeling hydrophobic interactions
34. Partial least squares regression - A tutorial
35. Chemometrics. I: Multivariate calibration: A tutorial
36. Structure of 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinil-1H- benzimidazole (omeprazole)
37. QSAR study of the toxicity of benzoic acids to Vibrio fischeri, Daphnia magna and carp